Alan Fournier's Strategic Moves in Q3 2024: A Deep Dive into TransDigm Group's Significant Reduction

In This Article:

Insights into the Investment Shifts of a Renowned Value Investor

Alan Fournier (Trades, Portfolio), the seasoned investor behind the transformation of his hedge fund into a family office, has recently disclosed his portfolio updates for the third quarter of 2024. Fournier, who began his career at Sanford C. Bernstein and later contributed significantly at Appaloosa Management, is known for his nuanced investment strategies that blend growth and value investing with sophisticated hedging and leverage techniques. His latest 13F filing reveals some intriguing adjustments to his investment holdings, reflecting his deep market analysis and strategic foresight.

Alan Fournier's Strategic Moves in Q3 2024: A Deep Dive into TransDigm Group's Significant Reduction
Alan Fournier's Strategic Moves in Q3 2024: A Deep Dive into TransDigm Group's Significant Reduction

Summary of New Buys

Alan Fournier (Trades, Portfolio)'s portfolio welcomed a new entrant in the third quarter of 2024:

  • The most significant addition was ASML Holding NV (NASDAQ:ASML), with 6,500 shares, accounting for 1.55% of the portfolio and a total value of $5.42 million.

Key Position Increases

Noteworthy increases were made in several existing positions:

  • Antero Resources Corp (NYSE:AR) saw an addition of 290,000 shares, bringing the total to 1,126,000 shares. This adjustment represents a significant 34.69% increase in share count, impacting the current portfolio by 2.37%, with a total value of $32,259,900.

  • Perimeter Solutions SA (NYSE:PRM) also saw an increase of 400,000 shares, bringing the total to 2,700,000. This adjustment represents a 17.39% increase in share count, with a total value of $36,315,000.

Summary of Sold Out Positions

Alan Fournier (Trades, Portfolio) exited several positions entirely in this quarter:

  • The ODP Corp (NASDAQ:ODP): All 400,000 shares were sold, impacting the portfolio by -4.11%.

  • Arcutis Biotherapeutics Inc (NASDAQ:ARQT): All 170,900 shares were liquidated, causing a -0.42% impact on the portfolio.

Key Position Reductions

Significant reductions were also observed in the portfolio:

  • TransDigm Group Inc (NYSE:TDG) saw a reduction of 13,000 shares, resulting in a -40.16% decrease in shares and a -4.34% impact on the portfolio. The stock traded at an average price of $1,300.33 during the quarter and has returned 13.26% over the past three months and 39.77% year-to-date.

  • Microsoft Corp (NASDAQ:MSFT) was reduced by 29,000 shares, resulting in a -36.25% reduction in shares and a -3.39% impact on the portfolio. The stock traded at an average price of $427.47 during the quarter and has returned 2.61% over the past three months and 14.17% year-to-date.

Portfolio Overview

As of the third quarter of 2024, Alan Fournier (Trades, Portfolio)'s portfolio included 16 stocks. The top holdings were 16.44% in EchoStar Corp (NASDAQ:SATS), 10.37% in Perimeter Solutions SA (NYSE:PRM), 10.08% in Micron Technology Inc (NASDAQ:MU), 9.68% in Amazon.com Inc (NASDAQ:AMZN), and 9.21% in Antero Resources Corp (NYSE:AR). The holdings are mainly concentrated in 8 of all the 11 industries: Technology, Industrials, Basic Materials, Consumer Cyclical, Energy, Communication Services, Utilities, and Financial Services.

Waiting for permission
Allow microphone access to enable voice search

Try again.